Page last updated: 2024-10-26

pentetic acid and Basal Ganglia Diseases

pentetic acid has been researched along with Basal Ganglia Diseases in 2 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goasguen, J1
Lapresle, J1
Ribot, C1
Rocquet, G1
Higano, S1
Takahashi, S1
Ishii, K1
Matsumoto, K1
Ikeda, H1
Sakamoto, K1

Other Studies

2 other studies available for pentetic acid and Basal Ganglia Diseases

ArticleYear
[Chronic neurological syndrome resulting from intoxication with metallic uranium (author's transl)].
    La Nouvelle presse medicale, 1982, Jan-16, Volume: 11, Issue:2

    Topics: Adult; Animals; Ataxia; Basal Ganglia Diseases; Chronic Disease; Feces; Humans; Male; Middle Aged; N

1982
Germinoma originating in the basal ganglia and thalamus: MR and CT evaluation.
    AJNR. American journal of neuroradiology, 1994, Volume: 15, Issue:8

    Topics: Adolescent; Atrophy; Basal Ganglia Diseases; Brain; Brain Neoplasms; Brain Stem; Calcinosis; Child;

1994